J Korean Med Assoc.  2017 Sep;60(9):753-758. 10.5124/jkma.2017.60.9.753.

Diagnosis and treatment of atopic dermatitis in children

• Pyun BY

• KMID: 2389795
• DOI: http://doi.org/10.5124/jkma.2017.60.9.753

Abstract

Atopic dermatitis (AD) is a common allergic inflammatory skin disorder characterized by chronically relapsing, often intensely pruritic eczematous lesions. AD occurs primarily in children, with a prevalence of 10% to 20% of children worldwide. The pathogenesis of AD is complex and multifactorial. Genetic factors, environmental factors, immune dysfunction, and skin barrier dysfunction play a role in its development. Because there is no definitive laboratory test, AD is diagnosed based on a combination of clinical symptoms. Regardless of the severity of the disease, skin-directed therapies, including skin care, trigger avoidance, and acute treatment for flares, should be implemented for every patient. Educating patients and family members regarding the pathogenesis of the disease, treatment goals, and prognosis plays an extremely important role in the management of AD. Personalized, optimized, and well-communicated treatment plans should be continually refined during regular follow-ups.

Keyword

Dermatitis; atopic; Child

MeSH Terms

Child*
Dermatitis
Dermatitis, Atopic*
Diagnosis*
Follow-Up Studies
Humans
Immunologic Factors
Prevalence
Prognosis
Skin
Skin Care
Immunologic Factors

Reference

1. Schneider L, Tilles S, Lio P, Boguniewicz M, Beck L, LeBovidge J, Novak N, Bernstein D, Blessing-Moore J, Khan D, Lang D, Nicklas R, Oppenheimer J, Portnoy J, Randolph C, Schuller D, Spector S, Tilles S, Wallace D. Atopic dermatitis: a practice parameter update 2012. J Allergy Clin Immunol. 2013; 131:295–299.

2. Park YM, Lee SY, Kim WK, Han MY, Kim J, Chae Y, Hahm MI, Lee KJ, Kwon HJ, Park KS, Park JS, Ahn K. Risk factors of atopic dermatitis in Korean schoolchildren: 2010 international study of asthma and allergies in childhood. Asian Pac J Allergy Immunol. 2016; 34:65–72.

3. Yu HS, Kang MJ, Jung YH, Kim HY, Seo JH, Kim YJ, Lee SH, Kim HJ, Kwon JW, Kim BJ, Yu J, Hong SJ. Mutations in the filaggrin are predisposing factor in Korean children with atopic dermatitis. Allergy Asthma Immunol Res. 2013; 5:211–215.

4. Hanifin JM, Rajka G. Diagnostic features of atopic eczema. Acta Derm Venereol Suppl (Stockh). 1980; 92:44–47.

5. Cho JE, Jeon YH, Yang HJ, Pyun BY. A study of the frequency and characteristics of minor clinical manifestations in children with atopic dermatitis. Korean J Pediatr. 2009; 52:818–823.

6. Katayama I, Aihara M, Ohya Y, Saeki H, Shimojo N, Shoji S, Taniguchi M, Yamada H. Japanese Society of Allergology. Japanese guidelines for atopic dermatitis 2017. Allergol Int. 2017; 66:230–247.

7. Elias PM, Eichenfield LF, Fowler JF Jr, Horowitz P, McLeod RP. Update on the structure and function of the skin barrier: atopic dermatitis as an exemplar of clinical implications. Semin Cutan Med Surg. 2013; 32:2 Suppl 2. S21–S24.

8. Eichenfield LF, Tom WL, Berger TG, Krol A, Paller AS, Schwarzenberger K, Bergman JN, Chamlin SL, Cohen DE, Cooper KD, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Margolis DJ, Silverman RA, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Sidbury R. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014; 71:116–132.

9. Sidbury R, Tom WL, Bergman JN, Cooper KD, Silverman RA, Berger TG, Chamlin SL, Cohen DE, Cordoro KM, Davis DM, Feldman SR, Hanifin JM, Krol A, Margolis DJ, Paller AS, Schwarzenberger K, Simpson EL, Williams HC, Elmets CA, Block J, Harrod CG, Smith Begolka W, Eichenfield LF. Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approaches. J Am Acad Dermatol. 2014; 71:1218–1233.

10. Ring J, Alomar A, Bieber T, Deleuran M, Fink-Wagner A, Gelmetti C, Gieler U, Lipozencic J, Luger T, Oranje AP, Schafer T, Schwennesen T, Seidenari S, Simon D, Stander S, Stingl G, Szalai S, Szepietowski JC, Taieb A, Werfel T, Wollenberg A, Darsow U. European Dermatology Forum (EDF). European Academy of Dermatology and Venereology (EADV). European Federation of Allergy (EFA). European Task Force on Atopic Dermatitis (ETFAD). European Society of Pediatric Dermatology (ESPD). Global Allergy and Asthma European Network (GA2LEN). Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol. 2012; 26:1045–1060.

11. Simpson E, Trookman NS, Rizer RL, Preston N, Colon LE, Johnson LA, Gottschalk RW. Safety and tolerability of a body wash and moisturizer when applied to infants and toddlers with a history of atopic dermatitis: results from an open-label study. Pediatr Dermatol. 2012; 29:590–597.

12. Wiren K, Nohlgard C, Nyberg F, Holm L, Svensson M, Johannesson A, Wallberg P, Berne B, Edlund F, Loden M. Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial. J Eur Acad Dermatol Venereol. 2009; 23:1267–1272.

13. Boralevi F, Saint Aroman M, Delarue A, Raudsepp H, Kaszuba A, Bylaite M, Tiplica GS. Long-term emollient therapy improves xerosis in children with atopic dermatitis. J Eur Acad Dermatol Venereol. 2014; 28:1456–1462.

14. Sher LG, Chang J, Patel IB, Balkrishnan R, Fleischer AB Jr. Relieving the pruritus of atopic dermatitis: a meta-analysis. Acta Derm Venereol. 2012; 92:455–461.

15. Jeong KY, Park JW, Hong CS. House dust mite allergy in Korea: the most important inhalant allergen in current and future. Allergy Asthma Immunol Res. 2012; 4:313–325.

16. Arshad SH, Bateman B, Sadeghnejad A, Gant C, Matthews SM. Prevention of allergic disease during childhood by allergen avoidance: the Isle of Wight prevention study. J Allergy Clin Immunol. 2007; 119:307–313.

17. Berth-Jones J, Damstra RJ, Golsch S, Livden JK, Van Hooteghem O, Allegra F, Parker CA. Multinational Study Group. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ. 2003; 326:1367.

18. Ference JD, Last AR. Choosing topical corticosteroids. Am Fam Physician. 2009; 79:135–140.

19. El-Batawy MM, Bosseila MA, Mashaly HM, Hafez VS. Topical calcineurin inhibitors in atopic dermatitis: a systematic review and meta-analysis. J Dermatol Sci. 2009; 54:76–87.

20. Wahn U, Bos JD, Goodfield M, Caputo R, Papp K, Manjra A, Dobozy A, Paul C, Molloy S, Hultsch T, Graeber M, Cherill R, de Prost Y. Flare Reduction in Eczema with Elidel (Children) Multicenter Investigator Study Group. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics. 2002; 110(1 Pt 1):e2.

21. Yang HJ, Min TK, Lee HW, Pyun BY. Efficacy of probiotic therapy on atopic dermatitis in children: a randomized, doubleblind, placebo-controlled Trial. Allergy Asthma Immunol Res. 2014; 6:208–215.

22. Stalder JF, Bernier C, Ball A, De Raeve L, Gieler U, Deleuran M, Marcoux D, Eichenfield LF, Lio P, Lewis-Jones S, Gelmetti C, Takaoka R, Chiaverini C, Misery L, Barbarot S. Oriented Patient-Education Network in Dermatology (OPENED). Therapeutic patient education in atopic dermatitis: worldwide experiences. Pediatr Dermatol. 2013; 30:329–334.

23. Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Cochrane Database Syst Rev. 2012; (9):CD000133.

24. Simpson EL, Berry TM, Brown PA, Hanifin JM. A pilot study of emollient therapy for the primary prevention of atopic dermatitis. J Am Acad Dermatol. 2010; 63:587–593.

25. Horimukai K, Morita K, Narita M, Kondo M, Kitazawa H, Nozaki M, Shigematsu Y, Yoshida K, Niizeki H, Motomura K, Sago H, Takimoto T, Inoue E, Kamemura N, Kido H, Hisatsune J, Sugai M, Murota H, Katayama I, Sasaki T, Amagai M, Morita H, Matsuda A, Matsumoto K, Saito H, Ohya Y. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol. 2014; 134:824–830.

26. Pyun BY. Natural history and risk factors of atopic dermatitis in children. Allergy Asthma Immunol Res. 2015; 7:101–105.